Decreased Maternal Plasma Apelin Concentrations in Preeclampsia
Decreased Maternal Plasma Apelin Concentrations in Preeclampsia
复制标题
DOI:
10.3109/10641955.2012.690054
复制
发表时间:
2012-01-01
影响因子:
1.5
通讯作者:
Maitra, Rangan
中科院分区:
文献类型:
--
作者:
Bortoff, Katherine D.;Qiu, Chunfang;Maitra, Rangan
Background. Preeclampsia is a hypertensive disorder that complicates 3-7% of pregnancies. The development of preeclampsia has not been completely elucidated and current therapies are not broadly efficacious. The apelinergic system appears to be involved in hypertensive disorders and experimental studies indicate a role of this system in preeclampsia. Thus, an epidemiological evaluation of apelin protein concentration in plasma was conducted in case-control study of pregnant women. Methods. Data and maternal plasma samples were collected from pregnant women with confirmed preeclampsia (n = 76) or normotensive controls (n = 79). Concentrations of apelin peptides were blindly measured using enzyme-linked immunosorbent assay. Data were subjected to statistical analyses. Results. Plasma apelin concentrations, measured at delivery, were lower in preeclampsia cases compared with controls (mean +/- standard deviation: 0.66 +/- 0.29 vs. 0.78 +/- 0.31 ng/mL, p = 0.02). After controlling for confounding by maternal age, smoking status, and pre-pregnancy body mass index, odds of preeclampsia were 48% lower for women with high versus low plasma apelin (>= 0.73 vs.